Screener
Mirum Pharmaceuticals, Inc. MIRM Contingent liabilities
Contingent liabilities at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s contingent liabilities?
- Mirum Pharmaceuticals, Inc. (MIRM) reported contingent liabilities of $24.8M in Q2 2026.
- What does contingent liabilities mean?
- Contingent liabilities as reported by Mirum Pharmaceuticals, Inc. Common Stock.
Ask your AI about Mirum Pharmaceuticals, Inc.'s contingent liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude